Jesse D Schold,Jordan R H Hoffman,Sumit Mohan,Alice L Gray,Rocio Lopez,Susana Arrigain,Deena Brosi,Ryan LaVanchy,S Ali Husain,Miko Yu,Elizabeth A Pomfret
{"title":"Association of the Initial Implementation of Continuous Distribution Allocation Policy with Outcomes for Lung Transplant Candidates by Blood Type.","authors":"Jesse D Schold,Jordan R H Hoffman,Sumit Mohan,Alice L Gray,Rocio Lopez,Susana Arrigain,Deena Brosi,Ryan LaVanchy,S Ali Husain,Miko Yu,Elizabeth A Pomfret","doi":"10.1016/j.ajt.2025.04.004","DOIUrl":null,"url":null,"abstract":"On 3/9/2023, allocation of donor lungs in the US changed to continuous distribution(CD). Initial implementation of policy was flawed due to a programming error affecting priority of candidates by blood type. While this issue was identified and addressed, the impact of initial policy implementation on blood type O candidates has not been rigorously evaluated. We used SRTR data to evaluate candidate(n=4,738) and recipient(n=4,437) outcomes following CD policy. Using cumulative incidence plots accounting for competing risks and multivariable Cox models, incidence of transplantation pre-policy was similar by blood type (8-month incidence 81.0% vs. 80.5% for blood types-A,B,AB and blood type-O respectively,p=0.57). Following CD policy, blood type-O candidates had lower incidence of transplantation relative to other blood types (8-month incidences 86.3% vs 92.1% respectively,p<0.001) with a significantly lower adjusted hazard ratio(AHR) for transplantation (AHR=0.67,95% C.I. 0.54-0.82). Blood type-O candidates were more likely Hispanic and 'Other' race and had higher rates of waitlist removal or death following CD (6.0% vs 2.9%,p=0.003). Among transplants performed prior to CD, 48% were blood type-O recipients compared to 40% post-CD, representing 138 fewer blood type-O transplants than expected. Type-O blood candidates had significant decline in prognosis relative to other blood groups following initial implementation of CD policy.","PeriodicalId":123,"journal":{"name":"American Journal of Transplantation","volume":"60 1","pages":""},"PeriodicalIF":8.9000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajt.2025.04.004","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
On 3/9/2023, allocation of donor lungs in the US changed to continuous distribution(CD). Initial implementation of policy was flawed due to a programming error affecting priority of candidates by blood type. While this issue was identified and addressed, the impact of initial policy implementation on blood type O candidates has not been rigorously evaluated. We used SRTR data to evaluate candidate(n=4,738) and recipient(n=4,437) outcomes following CD policy. Using cumulative incidence plots accounting for competing risks and multivariable Cox models, incidence of transplantation pre-policy was similar by blood type (8-month incidence 81.0% vs. 80.5% for blood types-A,B,AB and blood type-O respectively,p=0.57). Following CD policy, blood type-O candidates had lower incidence of transplantation relative to other blood types (8-month incidences 86.3% vs 92.1% respectively,p<0.001) with a significantly lower adjusted hazard ratio(AHR) for transplantation (AHR=0.67,95% C.I. 0.54-0.82). Blood type-O candidates were more likely Hispanic and 'Other' race and had higher rates of waitlist removal or death following CD (6.0% vs 2.9%,p=0.003). Among transplants performed prior to CD, 48% were blood type-O recipients compared to 40% post-CD, representing 138 fewer blood type-O transplants than expected. Type-O blood candidates had significant decline in prognosis relative to other blood groups following initial implementation of CD policy.
期刊介绍:
The American Journal of Transplantation is a leading journal in the field of transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science. Published monthly, it provides an essential resource for researchers and clinicians worldwide.
The journal publishes original articles, case reports, invited reviews, letters to the editor, critical reviews, news features, consensus documents, and guidelines over 12 issues a year. It covers all major subject areas in transplantation, including thoracic (heart, lung), abdominal (kidney, liver, pancreas, islets), tissue and stem cell transplantation, organ and tissue donation and preservation, tissue injury, repair, inflammation, and aging, histocompatibility, drugs and pharmacology, graft survival, and prevention of graft dysfunction and failure. It also explores ethical and social issues in the field.